Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Riddles in Protein Molecular Structure Solved with New Application

By LabMedica International staff writers
Posted on 09 May 2011
A tool has been designed to determine the molecular configuration of proteins.

An international collaboration has led to a new, high-performance application that rapidly determined the structure of protein molecules in several cases where previous techniques had failed.

The effectiveness of the new method was reported online May 1, 2011, in the journal Nature. More...
The lead authors were Dr. Frank DiMaio of the University of Washington (UW; Seattle, USA) and Dr. Thomas C. Terwilliger of Los Alamos [US] National Laboratory (NM, USA). The senior author was Dr. David Baker, from the UW department of biochemistry.

A protein's molecular structure shapes its functions. In biomedical and health research, for example, scientists are interested in the molecular structure of specific proteins for many reasons, a few of which are (1) to design drugs that selectively target, at the molecular level, specific biochemical reactions in the body; (2) to understand abnormal human proteins in disease, and how these abnormal proteins cause malfunctions; (3) to learn the shape and function of virus particles and how they act to cause infections; (4) to see how the chains of amino acids, decoded from the DNA in genes, fold and twist into normally or abnormally shaped protein molecules; (5) to design new proteins not found in the nature; (6) to find ways to replace malfunctioning molecular parts of proteins that are vital to health; (7) lastly, to devise nanoscale tools.

"The important new method described…in Nature highlights the value of computational modeling in helping scientists to determine the structures and functions of molecules that are difficult to study using current techniques,” said Dr. Peter Preusch, who oversees Dr. Baker's research grant and other structural biology grants at the US National Institutes of Health (NIH; Bethesda, MD, USA). "Expanding the repertoire of known protein structures--a key goal of the NIH Protein Structure Initiative, which helped fund the research--will be of great benefit to scientists striving to design new therapeutic agents to treat disease.”

The methods devised by the group overcome some of the limitations of X-ray crystallography in determining the molecular structure of a protein. X-ray crystallography obtains data about the positions of atoms, chemical bonds, the density of electrons and other arrangements within a protein molecule.

The information is gleaned by striking protein crystals with X-ray beams, which bounce off in several directions. Measuring the angles and intensities of these diffracted beams enables scientists to generate a three-dimensional (3D) image of electron density. However, information about the molecular structure can be lost in taking the measurements, due to restraints posed by physics.

Scientists attempt to avoid this problem by comparing the crystallography results to previously solved protein structures that resemble the unknown structure. The technique to "fill in the blanks” is called molecular replacement. Molecular replacement has its own limitations in understanding the electron density maps produced by X-ray crystallography, according to the authors of the paper. Techniques such as automatic chain tracing frequently follow the comparative model more closely than the actual structure of the protein under question. These errors lead to failure to obtain an accurate configuration of the molecule.

The researchers demonstrated that this limitation could be considerably reduced by combining computer algorithms for protein structure modeling with those for determining structure via X-ray crystallography.

Several years ago, University of Washington researchers and their colleagues developed a structure prediction method called Rosetta. This program takes a chain of amino acids and searches for the lowest energy conformation possible from folding, twisting, and packing the chain into a 3D molecule.

The researchers discovered that even very poor electron density maps from molecular replacement solutions could be useful. These maps could guide Rosetta structural prediction searches that are based on energy optimization. By taking these energy-optimized predicted models, and searching for consistency with the electron density data contained in the X-ray crystallography, new maps were generated. The new maps were then subjected to automatic chain tracing to generate 3D models of the protein molecular structure. The models were checked with an advanced monitoring technique to see if any are successful.

To evaluate the performance of their new integrated method, the researchers looked at 13 sets of X-ray crystallography data on molecules whose structures could not be solved by expert crystallographers. These structures remained unsolved even after the application of an extensive array of other approaches. The new integrated method was able to yield high-resolution structures for eight of these 13 highly challenging models.

"The results show that structural prediction methods such as Rosetta can be even more powerful when combined with X-ray crystallography data,” the researchers noted. They added that the integrated approach likely outperforms others because it provides physical chemistry and protein structural information that can guide the massive sampling of candidate configurations. These data eliminate most conformations that are not physically possible.

These procedures, the authors noted, required significant computation, as up to several thousand Rosetta model predictions are generated for each structure. The researchers have developed automated procedures that potentially could taper down the possibilities and lessen the number of times a model is rebuilt to make corrections. This automation could reduce computing time.

Through Dr. Baker's laboratory, many members of the general public contribute their unused home computer time to help in the effort to obtain structural models of proteins that are biologically and medically significant. The scientific discovery game is called "Fold It,” which can be accessed online (please see Related Links below).

Related Links:

University of Washington
Los Alamos US National Laboratory
Fold It




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology System
Medonic M16C
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.